Skip to content

Clinical trials

Phase 2 Recurrence trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Country / region: South Korea Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20093
20102
20112
20124
20132
20143
20153
20166
20171
20183
20192
20204
20213
20227
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status15
Terminated6
Recruiting5
Active, not recruiting4
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Seoul National University Hospital5
Yonsei University5
Samsung Medical Center4
Korea Cancer Center Hospital3
Merck Sharp & Dohme LLC3
National Cancer Center, Korea3
Asan Medical Center1
Chonnam National University Hospital1
Clovis Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence56
Neoplasm Metastasis7
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Non-Hodgkin6
Lymphoma4
Lymphoma, B-Cell4
Head and Neck Neoplasms3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3
Lymphoma, Mantle-Cell3

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.